Insider filing · INCY
Mohamed Khairie Issa
EVP, Head of US Oncology
profile →
Incyte Corporation
INCY · Healthcare · 38 filings in 24 months
ticker →
Mohamed Khairie Issa sold $1.2M of Incyte (INCY)
Executed Jan 7, disclosed Jan 8, 1 day later.
Value, as filed
$1.2M
10,856 sh × $109.07
Executed
Jan 7
the trade date, as filed
Disclosed
Jan 8
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MIMohamed Khairie Issa (EVP, Head of US Oncology) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Incyte Corporation (INCY). The largest single filing was $1.2M of INCY (10,856 sh × $109.07, as filed), executed Jan 7.
The name
INCYHealthcare · Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Mohamed Khairie Issa in INCY
INCYSALE
Incyte Corporation
$126K1,093 sh × $115.01
Exec Jul 16
Filed Jul 20 · 4:09 PM ET